Important: Hydroxycut Lawsuits Have Already Been Reported
On May one, 2009, there was a recall of fourteen Hydroxycut diet-aid products springing from a number of reports that people using the products were developing significant liver problems and other health concerns. Less than a week later, on May 4, the 1st Hydroxycut class action court action was filed against the company that manufactures the products, Iovate Medical Sciences. The Hydroxycut Case alleges company failure in informing the public about potential hazards of the products. Naturally, it’s too soon to grasp the suit is going to turn out, but if the company had information which it didn’t divulge to consumers, it should definitely be held accountable.
A class action court action is filed by a bunch of people, all of whom have similar claims against a certain company. Filing a class action is just as effective, and a lot less dear, than filing an individual suit. As a rule, filing a class action court action will not cost you anything unless there is a settlement. At that time, the lawyer who handled the suit will take his fees from the compensation that got given and then share the remaining funds to the plaintiffs in the case. Since this is the case, you’ll be ready to file a Hydroxycut class action suit without paying a penny out of your own pocket, which is one of the reasons that class action suits became so popular.
The 1st class action lawsuit against Iovate was filed in Canada where the company is found and represents all Canadian citizens who sustained health problems due to Hydroxycut products. The FDA recall happened in the U. S. where twenty-three cases of liver disorders and other health problems had been reported. Health Canada did not receive any reports of liver damage caused by the diet products, but they did receive seventeen reports concerning folks who sustained respiration, neurological, heart, and stomach problems as a result of Canadians using the products.
The Hydroxycut Lawsuit alleges the company sold the products without correctly informing the products without properly informing the public of the health risks that they could exposing patrons to. The complaint states that the company failed to publish the data on the product labels saying that users could run the risk of liver and kidney damage as well as gastrointestinal, cardiovascular, respiratory, and neurological problems. The suit goes on to claim this was a blatant omission on the part of the company which purposely misled buyers concerning the safety of the products.
